SUMMARY
Cardiovascular disease remains the number one global cause of death and presents as multiple phenotypes in which the interplay between cardiomyocytes and cardiac fibroblasts (CFs) has become increasingly highlighted.
Fetal and adult CFs influence neighboring cardiomyocytes in different ways. Thus far, a detailed comparison between the two is lacking. Using a genome-wide approach, we identified and validated 2 crucial players for maintaining the adult primary human CF phenotype. Knockdown of these factors induced significant phenotypical changes, including senescence and reduced collagen gene expression. These may now represent novel thera- Common features of fibroblasts are the lack of a basement membrane, profound granular material in the cytoplasm scattered along a large Golgi apparatus, and a substantial rough endoplasmic reticulum (7) . A unique marker for fibroblasts or CFs is still lacking, although both fetal and adult CF express periostin, discoidin domain receptor 2, and vimentin (8) . Another feature of CFs is their ability to transform into an active state; the myofibroblast. Myofibroblasts express smooth muscle cell markers (e.g., smooth muscle actin
[SMA]) and may contract. They have also been implicated in wound contraction, fibrosis, and scar healing and are a source of cytokines and growth factors, such as IL-6 and transforming growth factor-b (9) .
Fibroblasts are abundant throughout all tissues in the body, and the population is heterogeneous, with diverse appearances and functions depending on where the cells reside (10) . Apart from the expression of common core fibroblast genes, a specific gene expression profile involving the cardiogenic transcriptional network has been described uniquely for CFs (11) . Furthermore, regional differences exist in which CFs from the atrium and the ventricle express different cardiogenic transcription factors (TFs) (11, 12) . Important differences have also been found between rat CFs from the embryonic heart compared with the adult heart, with a differential response in insulin-like growth factor-induced collagen production (13) . The influence of CFs on co-cultured CMs also varies depending on age. Embryonic CFs increase proliferation of CMs, whereas adult CFs induce hypertrophy (6) . Notably, this finding is consistent with the growth of a fetal or neonatal heart, which depends on the proliferation of CMs, whereas the adult heart responds to stress by hypertrophy. The diversity of the CF population is also underlined by the finding that CF may be derived from at least 3 sources: from the proepicardium, from endocardial-or epicardial-to-mesenchymal transformation (EMT), and from bone marrow (14) (15) (16) .
Despite increasing attention to the potential role that CF may play in novel disease therapeutics (17), a detailed genome-wide characterization of the genetic and epigenetic profiles of CF has yet to be performed.
In the present study, we conducted next-generation sequencing experiments with primary ventricular fetal human cardiac fibroblasts (fHCFs) and adult human cardiac fibroblasts (aHCFs) to carefully map their respective transcriptomic and epigenomic Jonsson et al.
Human Adult and Fetal Cardiac Fibroblast Epigenomes Table 1 .
Immunocytochemical labeling was performed for vimentin and Ki67 (proliferation marker). Representative images are shown in Figure 1A and are quantified in Figure 1B . Image analysis of more than 2,000 cells in independent cultures showed that fHCFs were consistently smaller than aHCFs (802 AE 46 mm 2 vs. Correlation comparisons between sample replicates in Figure 2C corroborate the distinction between aHCFs and fHCFs (correlation of fHCF replicates in blue is w0.98, and the same for aHCF replicates in red, contrasting against lower correlations compared across fHCFs and aHCFs in purple).
We next sought to interpret gene expression signatures that distinguished between fHCFs and aHCFs and started by performing Ingenuity Pathway Analysis (IPA, Qiagen GmbH, Hilden, Germany).
Supplemental Table 2 Table 1) . PLAGL1 and STAT1 knockdown led to >80% reduced expression levels when targeted with GapmeRs ( Figure 4B , Supplemental Figure 6B ).
Interestingly, PLAGL1 knockdown also led to reduced 
The intensity of the signal is ranked from -(no signal) to þþþ (strong signal) according to the criteria grouped as noted here. Ribonucleic acid-sequencing (RNA-seq): þþþ, >800.00; þþ, 100.00 to 799.99; þ, 10.00 to 99.99; þ/-, 2.00 to 9.99; and -, <2.00. Assay for transposase accessible chromatin-sequencing (ATAC-seq)/histone chromatin immunoprecipitation-sequencing (ChIP-seq): þþþ, >15; þþ, 10 to 15; þ, 5 to 10; þ/-, 2 to 5; and -, <2.
HCF ¼ human cardiac fibroblast.
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Human Adult and Fetal Cardiac Fibroblast Epigenomes D E C E M B E R 2 0 1 6 : 5 9 0 -6 0 2 STAT1 levels, suggesting an upstream effect of PLAGL1 on STAT1 that has not been previously reported. Negative A GapmeR construct, vehicle transfection, and nontransfected control specimens were used in all assessments. Cells were stained with antibodies against vimentin and Ki67 and analyzed for cell size, roundness, cell cycle, and cell number (n ¼ 3).
Cell size, morphology, or cell number was unchanged in all control specimens ( Figures 4C and 4D) .
Instead, knockdown of STAT1 significantly increased cell roundness, reduced cell number without increasing cell proliferation, and knockdown of either TF changed aHCF cell size ( Figure 4D , replicated in independent cell isolates in Supplemental Figure 6C ).
Changes at the transcriptional level revealed that whereas VIM and SMA were unchanged, both STAT1
and PLAGL1 knockdown caused significant downregulation of other genes previously noted as being characteristic of the aHCF phenotype (ELN, TNFRSF11B, COL1A1, and COL1A2). Conversely, HBEGF associated with the fetal gene profile was upregulated ( Figure 5A , also replicated in independent cell isolates in Supplemental Figure 6D ).
To test whether knockdown fibroblasts underwent mesenchymal epithelial transition (21) , key markers for epithelial cells (CDH1, KRT9, and ATP2C2) were quantified, but these remained poorly expressed or undetected, rejecting the possibility that this transition had taken place (Supplemental Figure 6D) . We next assessed for apoptosis by using the ApopTagRed assay. Baseline apoptosis of aHCFs in culture was 3% (untreated cells, n ¼ 5,237), 5% (cells treated Instead, we observed a striking exclusivity in which nuclei displaying the heterochromatin foci were never positive for Ki67 ( Figure 5D ). Together, these findings suggest that whereas 1 subset of knockdown aHCFs undergoes apoptosis, another appears to become senescent. Furthermore, STAT1 and PLAGL1 knockdown led to a significant reduction in collagen COL1A1 and COL1A2 gene expression ( Figure 5A ).
These results were again supported by RT-qPCR in all additional sets of aHCF cells.
DISCUSSION
Results of previous studies indicated that fHCFs and aHCFs are different in that they influence neighboring CMs in distinct ways (6, 13) . In the present study, we have further defined their distinct differences by performing a thorough characterization of primary fetal and adult human ventricular CFs by using cellular, molecular, and genome-wide sequencing approaches. Our results show that fHCFs are smaller and proliferate more quickly than their adult counterpart. We hypothesized that these characteristics are explained by differences in their transcriptomes and epigenomes. Indeed, genome-wide analyses of RNA-seq, ATAC-seq, and histone ChIP-seq led us to 2
TFs, highly expressed in aHCFs but not in fHCFs. We performed functional validation to conclude that they regulate aHCF cell size, cell cycle re-entry, and cell survival. Knockdown of either of the 2 TFs led to a destabilization of the aHCF phenotype and reduced gene expression of collagen genes, a major constituent of pathological fibrosis in the adult heart.
RNA-seq CONFIRMS FIBROBLAST IDENTITY AND IDENTIFIES DIFFERENTIAL SIGNALING PATHWAYS.
We first confirmed that "core" genes that define a fibroblast and that are typically used as fibroblast markers, such as VIM, THY1, DDR2, and COL1A2, do not differ in expression between fHCFs and aHCFs.
According to IPA analysis, 3 top functions found in the overlapping transcriptomes of the fHCFs and aHCFs are tissue development, cardiovascular system development and function, and organismal development, validating our cardiac cell source and Further in vivo studies will be needed to determine whether they do indeed represent potential drug targets for steering away the malevolent behavior of CFs during adult heart disease progression.
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